The new small molecule, inh-2, which inhibits RNF5, led to a notable rescue of F508del-CFTR in both immortalized and primary bronchial epithelial cells from CF patients who are homozygous for the F508del mutation. Here, RNF5 is linked to cystic fibrosis.